Breaking Down Walls in Trump’s Anti-Immigrant Rhetoric
TAGline • 2017How the Trump administration’s anti-immigrant stance threatens human rights, public health, and the lives of people living with TB By Erica Lessem and Suraj Madoori Perhaps the most recognizable symbol of the current presidential administration and the campaign that led Donald Trump to the White House is the wall. In 2015, then-candidate Trump first announced his…
Everybody In, Nobody Out
TAGline • 2017By Tim Horn Arguments favoring universal health care (UHC) are easy. Achieving political consensus as to the best strategy to achieve this is considerably more vexing. This is particularly true in the U.S., where the Affordable Care Act (ACA) patchwork of legislation and regulations has faced a barrage of executive and legislative attacks since the…
Coverage Isn’t Care
TAGline • 2017Globalizing the insurance model will harm global public health By Annette Gaudino In the New York City of the 1850s, firefighting was a private enterprise. Homeowners and landlords purchased insurance plans that included protection from a dedicated fire brigade. When a fire broke out, brigades would arrive on the scene and look for an insurance…
Remarks by Erica Lessem on TB research at the WHO Global Ministerial Conference on Ending TB
Webinars • 2017Remarks by Erica Lessem, Deputy Executive Director – TB Project Global Ministerial Conference on Ending TB in the Sustainable Development Era Moscow, Russian Federation November 17, 2017 Using lessons learnt from HIV, how do you see civil society and advocacy communities’ role in helping increase financial commitment by the global community to close the gap…
US Health & Human Services (HHS) Strategic Plan FY 2018-2022: TAG Comments to the Assistant Secretary for Planning and Evaluation
Letters • 2017TAG comments submitted to the Strategic Planning Team at the Office of the Assistant Secretary for Planning and Evaluation regarding the HHS Strategic Plan FY 2018-2022. The HHS Strategic Plan should set a precedent for reducing the burden of disease nationally through its focus on access to affordable treatment, advancement of research, implementation of evidence-based interventions, expansion of populations served, and inclusion of all stakeholders.
Division of AIDS Clinical Trials Networks Recompetition for 2020–2027 – Comments and Recommendations from TAG
Letters • 2017TAG’s comments on the Divisions of AIDS (DAIDS) in advance of the recompetition of its clinical trials networks.
Submission to the Office of the United Nations High Commissioner for Human Rights to Report on Sustainable Development Goals and Health
Letters • 2017A review of comments submitted by TAG to the Office of the United Nations High Commissioner for Human Rights, in response to a request for submissions from interested organizations and stakeholders for the preparation of its report on Sustainable Development Goals and Health.
TAG’s Annual Pipeline Report: Promising New HIV, TB & HCV Drugs and Diagnostics
Statement / Press • 2017Treatment Action Group (TAG) announces the launch of its annual research and development landscape analysis: The Pipeline Report: Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development.
The TB Prevention Pipeline
Pipeline • 2017July 2017 By Mike Frick INTRODUCTION One of the tuberculosis (TB) field’s most often voiced truisms has been that one-third of humanity is infected with Mycobacterium tuberculosis (MTB), the causative agent of TB disease. This estimate is invoked so frequently that it has become conventional wisdom and outgrown the need for a citation. A new…
The Tuberculosis Diagnostics Pipeline
Pipeline • 2017July 2017 By Erica Lessem INTRODUCTION Diagnosing tuberculosis (TB) is the first step to being able to treat it and prevent transmission. New guidelines from the World Health Organization (WHO) note that diagnosis should be “available free of charge to all persons with TB and populations at risk.”1 Yet an estimated over four million people…